STOCK MARKET BSE NSE

'Quest' for HIV Trials Results in WHO Rebuke

Published: 08th July 2015 04:02 AM  |   Last Updated: 08th July 2015 04:02 AM   |  A+A-

HYDERABAD:Chennai-based Quest Life Sciences has come under the scanner of the World Health Organization (WHO) for ‘critical’ lapses in conducting clinical trials for Micro Labs’ HIV drugs. The WHO had issued a ‘notice of concern’ to Quest last week following an inspection in October 2014.

This is the second such instance in the recent past where homegrown Clinical Research Organisations (CRO) have been pulled up for non-compliance by global health regulators.

Last year, the European Medicines Agency (EMA) had found fault with the BE/BA studies conducted by Hyderabad-based GVK Biosciences on behalf of several companies, including multi-nationals.

Quests’ ‘critical’ lapses were found in a trial it had done on Micro Labs’ HIV-treatment drugs Lamivudine Zidovudine Nevirapine dispersible tablets.

“The inspection revealed critical and major deviations from the WHO Good Clinical Practices (GCP) and Good Laboratory Practices (GLP) standards as specified in WHO publications,” the WHO said in its notice issued to Quest.

It added that more than 67 per cent of the pre-study electrocardiograms (ECGs) were duplicates and in one instance, a single ECG was reused up to nine times for different subjects.

“This means that the ECGs may not have been performed or were unreliable and therefore ineligible/unfit subjects could have been used in the study and protocol requirements have not been met,” the WHO noted, adding, “An apparent attempt was made to hide documents from inspectors by laboratory staff of Quest.”

Stay up to date on all the latest Hyderabad news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp